Stockscreener 앱 받기
19.76
0.82%
0.16
전일 마감가:
$19.60
열려 있는:
$19.39
하루 거래량:
3.80M
Relative Volume:
1.39
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+6.64%
1개월 성능:
-1.00%
6개월 성능:
-66.11%
1년 성능:
-71.57%
1일 변동 폭
$18.23
$19.91
1주일 범위
$17.85
$20.22
52주 변동 폭
$16.25
$160.50
Direxion Daily S P Biotech Bear 3 X Shares Stock (LABD) Company Profile
명칭
Direxion Daily S P Biotech Bear 3 X Shares
전화
-
주소
-
Compare LABD vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LABD
Direxion Daily S P Biotech Bear 3 X Shares
|
19.76 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.65 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.75 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.76 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
276.30 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
601.92 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily S P Biotech Bear 3 X Shares 주식(LABD)의 최신 뉴스
5 Small-cap Biotech ETFs to Watch - Investing News Network
A Leveraged Bet on the Broad Market or Big Tech: SPXL vs. QLD - The Motley Fool
Avoiding Lag: Real-Time Signals in (LABD) Movement - Stock Traders Daily
EDC: A Highly Leveraged Play On The Daily Movements Of Emerging Markets (NYSEARCA:EDC) - Seeking Alpha
These 2 ETFs Have Been Red-Hot: Can it Continue? - The Motley Fool
GUSH: Examining The Structure And Suitability Of This 2X Leveraged ETF - Seeking Alpha
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
Discipline and Rules-Based Execution in LABD Response - Stock Traders Daily
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD) - Seeking Alpha
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF (NYSEARCA:LABU) - Seeking Alpha
NAIL: Favorable Macroeconomic Outlook For 2026-2027 (NYSEARCA:NAIL) - Seeking Alpha
SOXL: Time To Cash In (NYSEARCA:SOXL) - Seeking Alpha
Behavioral Patterns of LABD and Institutional Flows - Stock Traders Daily
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 - 24/7 Wall St.
Short Interest in Direxion Daily BRKB Bull 2X Shares (NASDAQ:BRKU) Drops By 40.8% - MarketBeat
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Hits New 52-Week HighTime to Buy? - MarketBeat
Direxion Daily MU Bull 2X Shares (NASDAQ:MUU) Short Interest Down 73.4% in December - MarketBeat
Direxion Daily TSM Bull 2X Shares (NASDAQ:TSMX) Short Interest Update - MarketBeat
Earn 8% and (Potentially) 3x the S&P’s Return This Year, but There Is a Catch - 24/7 Wall St.
Bet Against Big Banks in 2026 With FAZ - 24/7 Wall St.
The 2X Long INTC (INTW) fund rose by 13.10% with a trading value of $111.98 million. - Sahm
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Shares Gap UpStill a Buy? - MarketBeat
Q4 Earnings: Beat, Miss, or Market Whiplash? - Direxion
Direxion Daily Natural Gas Related Bear 3x Shares Direxion Shares ETF Trust - GuruFocus
(LABD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Direxion’s Aerospace & Defense ETF Is Up Almost 150% - 24/7 Wall St.
Direxion Daily MU Bull 2X Shares (NASDAQ:MUU) Short Interest Up 51.8% in December - MarketBeat
Direxion Daily TSM Bull 2X Shares (NASDAQ:TSMX) Short Interest Down 38.3% in December - MarketBeat
Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.2287 - MSN
Why (LABD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Direxion Daily BRKB Bull 2X Shares (NASDAQ:BRKU) Declares Quarterly Dividend of $0.21 - MarketBeat
Direxion Daily MSFT Bull 2X Shares (NASDAQ:MSFU) Declares $0.27 Quarterly Dividend - MarketBeat
Direxion Daily AVGO Bull 2X Shares (NASDAQ:AVL) Announces $0.16 Quarterly Dividend - MarketBeat
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Announces Quarterly Dividend of $0.34 - MarketBeat
RDVY First Trust Rising Dividend 69.90$ +0.68%eToro - eToro
RS2K.PA Amundi Russell 2000 UCITS ETF 323.10€ +1.47%eToro - eToro
How to Trade Biotech’s Volatility with LABU/LABD | CRISPR & Cancer Stocks - ETFguide
NUGT: A Primer On The Structure And Suitability Of This 2x Leveraged ETF - Seeking Alpha
Oil Nears A Rough End To 2025, But These Energy ETFs Can Keep Traders In The Game - Benzinga
NAIL: Leveraged Exposure To The Homebuilding Industry (NYSEARCA:NAIL) - Seeking Alpha
(LABD) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
CURE: The Leveraged ETF That Turbocharges The Leading U.S. Healthcare Stocks (CURE) - Seeking Alpha
TSLL Stock Outlook: Is Direxion’s 2X Tesla ETF Still Worth the Risk After December’s Rally? - TechStock²
(LABD) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
TNA: Small Caps Could Benefit From U.S. Economy Uptick In 2026 (NYSEARCA:TNA) - Seeking Alpha
CURE: Analysts Strike A Cautious Tone Heading Into 2026 (NYSEARCA:CURE) - Seeking Alpha
(LABD) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
TECL: Risks And Rewards Of The Leveraged Bull (TECL) - Seeking Alpha
Top Performing Leveraged/Inverse ETFs: 11/16/2025 - ETF Database
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Sets New 1-Year HighWhat's Next? - MarketBeat
3 Reasons FIVN is Risky and 1 Stock to Buy Instead - Barchart.com
Direxion Daily S P Biotech Bear 3 X Shares (LABD) 재무 분석
Direxion Daily S P Biotech Bear 3 X Shares (LABD)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.74%
0.47%
자본화:
|
볼륨(24시간):